EOS Imaging

About

EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology.

Paris,Ile-de-France,France
101 - 250

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $18M
Industries: 3D Technology,Health Care,Medical Device
Founded date: Jan 1, 1989
Number Of Employee: 101 - 250
Operating Status: Active
Stock Symbol: epa:EOSI
Legal Name: EOS imaging, SA

EOS imaging is a medical company revolutionizing the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopedic surgeries.

Its EOS® 2D/3D imaging system is specifically adapted to the needs of orthopedic surgeons and radiologists. This personalized imaging tool gives a precise 3D image of the patient's skeleton in the upright position that can be used to inform all aspects of care. The Company has obtained authorization to market the system in 48 countries. The Company is based in Paris, with a subsidiary in the United States in Cambridge, Massachusetts, as well as offices in Montreal (Canada) and Germany.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$18M €37.80M

EOS Imaging has raised a total of $18M €37.80M in funding over 2 rounds. Their latest funding was raised on Dec 10, 2018 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 10, 2018	Post-IPO Equity	€15M	1	Fosun Pharma	—	Detail
Apr 21, 2017	Post-IPO Equity	€7.80M	—	—	—	Detail
Jan 14, 2015	Post-IPO Debt	€15M	1	—	—	Detail
Feb 24, 2012	IPO	—	—	—	—	Detail
Nov 27, 2007	Series Unknown	$18M	4	Crédit Agricole NBGI Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

6

EOS Imaging is funded by 6 investors. Fosun Pharma and Crédit Agricole are the most recent investors.

Investor Name	Lead Investor	Funding Round
Fosun Pharma	Yes	Post-IPO Equity
Crédit Agricole	Yes	Series Unknown
NBGI Ventures	Yes	Series Unknown
IPF Partners	—	Post-IPO Debt
Andera Partners	—	Series Unknown
UFG Private Equity	—	Series Unknown